Adjuvant capecitabine for early triple-negative breast cancer: A meta-analysis of randomized controlled trials

被引：1
|
作者：
Liu, Mei [1 ]
Fang, Huiying [1 ]
Qian, Shengqiang [2 ]
机构：
[1] Chongqing Univ, Chongqing Key Lab Translat Res Canc Metastasis &, Canc Hosp, Chongqing 400030, Peoples R China
[2] Chongqing Hosp Tradit Chinese Med, Dept Urol, Chongqing 400000, Peoples R China
来源：
ASIAN JOURNAL OF SURGERY | 2022年 / 45卷 / 09期
关键词：
D O I：
10.1016/j.asjsur.2022.01.039
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：1748 / 1750
页数：3
相关论文
共 50 条
  • [31] Survival benefit of platinum-based regimen in early stage triple negative breast cancer: A meta-analysis of randomized controlled trials
    Bian, Lei
    Yu, Ping
    Wen, Jiahuai
    Li, Na
    Huang, Wanwei
    Xie, Xiaoming
    Ye, Feng
    [J]. NPJ BREAST CANCER, 2021, 7 (01)
  • [32] Survival benefit of platinum-based regimen in early stage triple negative breast cancer: A meta-analysis of randomized controlled trials
    Lei Bian
    Ping Yu
    Jiahuai Wen
    Na Li
    Wanwei Huang
    Xiaoming Xie
    Feng Ye
    [J]. npj Breast Cancer, 7
  • [33] Adjuvant Denosumab treatment in early breast cancer: a systematic review and meta-analysis of randomized controlled clinical trials
    Mastrantoni, Luca
    Garufi, Giovanna
    Di Monte, Elena
    Maliziola, Noemi
    Pasqualoni, Mariangela
    Pontolillo, Letizia
    Pannunzio, Sergio
    Cannizzaro, Maria Chiara
    Di Bello, Armando
    Fabi, Alessandra
    Palazzo, Antonella
    Bria, Emilio
    Tortora, Giampaolo
    Orlandi, Armando
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [34] Hypofractionated Radiotherapy as Adjuvant Treatment in Early Breast Cancer. A Review and Meta-Analysis of Randomized Controlled Trials
    Budach, Wilfried
    Bolke, Edwin
    Matuschek, Christiane
    [J]. BREAST CARE, 2015, 10 (04) : 240 - 245
  • [35] Neo-adjuvant therapy for triple-negative breast cancer: Insights from a network meta-analysis
    Miyashita, Hirotaka
    Satoi, Sera
    Cruz, Christina
    Malamud, Stephen C.
    [J]. BREAST JOURNAL, 2020, 26 (09): : 1717 - 1728
  • [36] Platinum-based neoadjuvant chemotherapy (NACT) in triple-negative breast cancer (TNBC): A systematic review and meta-analysis of randomized controlled trials (RCTs)
    Poggio, Francesca
    Bruzzone, Marco
    Ceppi, Marcello
    Ponde, Noam Falbel
    La Valle, Giovanni
    Sotiriou, Christos
    Del Mastro, Lucia
    De Azambuja, Evandro
    Lambertini, Matteo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [37] A meta-analysis of biomarkers for the prognosis of triple-negative breast cancer patients
    Gui, Yu
    Xu, Shuman
    Yang, Xi
    Gu, Lu
    Zhang, Ze
    Luo, Xiangdong
    Chen, Li
    [J]. BIOMARKERS IN MEDICINE, 2016, 10 (07) : 771 - 790
  • [38] Extended duration of adjuvant aromatase inhibitor in breast cancer: a meta-analysis of randomized controlled trials
    Clement, Zackariah
    Kollias, James
    Bingham, Janne
    Whitfield, Robert
    Bochner, Melissa
    [J]. GLAND SURGERY, 2018, 7 (05) : 449 - 457
  • [39] Adjuvant Capecitabine in Triple-Negative Breast Cancer New Strategies for Tailoring Treatment Recommendations
    Parsons, Heather A.
    Burstein, Harold J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (01): : 36 - 38
  • [40] CBCSG-10, the addition of capecitabine to adjuvant chemotherapy in triple-negative breast cancer
    Li, J.
    Shao, Z.
    Yang, S.
    Jiang, J.
    Wang, C.
    Liu, Y.
    Fu, P.
    Pang, D.
    Sheng, Y.
    [J]. BREAST, 2015, 24 : S53 - S53
12345